Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Cameroni

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Cell Reports|June 24, 2021
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7Bo Meng, Steven A Kemp, Guido Papa, et al.
Science Signaling|February 18, 2010
Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifsJanine Mok, Philip M Kim, Hugo Y K Lam, et al.
Cell|September 23, 2017
A Human Bi-specific Antibody against Zika Virus with High Therapeutic PotentialJiaqi Wang, Marco Bardelli, Diego A Espinosa, et al.
Science (New York, N.Y.)|February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibodyDavide Corti, John Misasi, Sabue Mulangu, et al.
Plos One|February 10, 2022
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsJessica Bassi, Olivier Giannini, Chiara Silacci-Fregni, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (New York, N.Y.)|July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccinesJohn E Bowen, Amin Addetia, Ha V Dang, et al.
Science (New York, N.Y.)|July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concernMatthew McCallum, Jessica Bassi, Anna De Marco, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Cell|March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Cell Reports|June 24, 2021
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7Bo Meng, Steven A Kemp, Guido Papa, et al.
Science Signaling|February 18, 2010
Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifsJanine Mok, Philip M Kim, Hugo Y K Lam, et al.
Cell|September 23, 2017
A Human Bi-specific Antibody against Zika Virus with High Therapeutic PotentialJiaqi Wang, Marco Bardelli, Diego A Espinosa, et al.
Science (New York, N.Y.)|February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibodyDavide Corti, John Misasi, Sabue Mulangu, et al.
Plos One|February 10, 2022
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsJessica Bassi, Olivier Giannini, Chiara Silacci-Fregni, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (New York, N.Y.)|July 20, 2022
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccinesJohn E Bowen, Amin Addetia, Ha V Dang, et al.
Science (New York, N.Y.)|July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concernMatthew McCallum, Jessica Bassi, Anna De Marco, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian Lempp, et al.
Cell|March 24, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2Matthew McCallum, Anna De Marco, Florian A Lempp, et al.
Pageof 7